Basic gene annotations are collected from Uniprot
and displayed with links to original sources. A quick link to explore the genomic context with Uniprot Browser
is available.
NFATC4 - nuclear factor of activated T cells 4
Function
Ca(2+)-regulated transcription factor that is involved in several processes, including the development and function of the immune, cardiovascular, musculoskeletal, and nervous systems (PubMed:7749981, PubMed:11514544, PubMed:11997522, PubMed:17875713, PubMed:17213202, PubMed:18668201, PubMed:25663301). Involved in T-cell activation, stimulating the transcription of cytokine genes, including that of IL2 and IL4 (PubMed:7749981, PubMed:18668201, PubMed:18347059). Along with NFATC3, involved in embryonic heart development. Involved in mitochondrial energy metabolism required for cardiac morphogenesis and function (By similarity). Transactivates many genes involved in the cardiovascular system, including AGTR2, NPPB/BNP (in synergy with GATA4), NPPA/ANP/ANF and MYH7/beta-MHC (By similarity). Involved in the regulation of adult hippocampal neurogenesis. Involved in BDNF-driven pro-survival signaling in hippocampal adult-born neurons. Involved in the formation of long-term spatial memory and long-term potentiation (By similarity). In cochlear nucleus neurons, may play a role in deafferentation-induced apoptosis during the developmental critical period, when auditory neurons depend on afferent input for survival (By similarity). Binds to and activates the BACE1/Beta-secretase 1 promoter, hence may regulate the proteolytic processing of the amyloid precursor protein (APP) (PubMed:25663301). Plays a role in adipocyte differentiation (PubMed:11997522). May be involved in myoblast differentiation into myotubes (PubMed:17213202). Binds the consensus DNA sequence 5'-GGAAAAT-3' (Probable). In the presence of CREBBP, activates TNF transcription (PubMed:11514544). Binds to PPARG gene promoter and regulates its activity (PubMed:11997522). Binds to PPARG and REG3G gene promoters (By similarity).
Uniprot BrowserEntrez ID | EnsEMBL ID | Preferred Name | Uniprot ID |
---|---|---|---|
4776 | ENSG00000100968 | NFATC4 | Q14934 |
Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator
which then might up- down-regulates a regulon
that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows with ENSG00000100968 as Regulator
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-00148 | LRP2 | up-regulates | NFATC4 | activates | R-2707 | 10 | 2 | Drugs (4) |
CMF-00357 | COL6A3 | up-regulates | NFATC4 | activates | R-2712 | 10 | 4 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-00358 | COL6A3 | up-regulates | NFATC4 | activates | R-2705 | 10 | 4 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)L19IL2, AS-1409, ALEPLASININ, L19TNFA, L19SIP 131I, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN |
CMF-00359 | COL6A3 | up-regulates | NFATC4 | activates | R-2710 | 10 | 4 | Drugs (1) |
CMF-00419 | MUC16 | down-regulates | NFATC4 | activates | R-2705 | 10 | 1 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)L19IL2, AS-1409, ALEPLASININ, L19TNFA, L19SIP 131I, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN |
CMF-00775 | TPTE2 | down-regulates | NFATC4 | activates | R-2705 | 10 | 3 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)L19IL2, AS-1409, ALEPLASININ, L19TNFA, L19SIP 131I, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN |
CMF-02357 | KCNH6 | down-regulates | NFATC4 | activates | R-2705 | 10 | 2 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)L19IL2, AS-1409, ALEPLASININ, L19TNFA, L19SIP 131I, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN |
CMF-04597 | LAMC3 | down-regulates | NFATC4 | activates | R-2712 | 10 | 3 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-04599 | LAMC3 | down-regulates | NFATC4 | activates | R-2707 | 10 | 3 | Drugs (4) |
CMF-07146 | ATRX | down-regulates | NFATC4 | activates | R-2712 | 10 | 7 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-07149 | ATRX | down-regulates | NFATC4 | activates | R-2705 | 10 | 7 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)L19IL2, AS-1409, ALEPLASININ, L19TNFA, L19SIP 131I, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN |
CMF-07150 | ATRX | down-regulates | NFATC4 | activates | R-2710 | 10 | 7 | Drugs (1) |
CMF-07151 | ATRX | down-regulates | NFATC4 | activates | R-2707 | 10 | 7 | Drugs (4) |
CMF-07547 | ANO7 | down-regulates | NFATC4 | activates | R-2710 | 10 | 2 | Drugs (1) |
CMF-08136 | PLEKHG4B | down-regulates | NFATC4 | activates | R-2712 | 10 | 3 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-14120 | HEATR7B2 | down-regulates | NFATC4 | activates | R-2705 | 10 | 2 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)L19IL2, AS-1409, ALEPLASININ, L19TNFA, L19SIP 131I, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN |
CMF-15056 | PTEN | up-regulates | NFATC4 | activates | R-2707 | 10 | 1 | Drugs (4) |
CMF-16260 | USP11 | down-regulates | NFATC4 | activates | R-2705 | 10 | 4 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)L19IL2, AS-1409, ALEPLASININ, L19TNFA, L19SIP 131I, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN |
CMF-16261 | USP11 | down-regulates | NFATC4 | activates | R-2710 | 10 | 4 | Drugs (1) |
CMF-16262 | USP11 | down-regulates | NFATC4 | activates | R-2707 | 10 | 4 | Drugs (4) |
CMF-18507 | LAMA1 | up-regulates | NFATC4 | activates | R-2710 | 10 | 2 | Drugs (1) |
CMF-19085 | COL4A4 | up-regulates | NFATC4 | activates | R-2710 | 10 | 1 | Drugs (1) |
CMF-19564 | NF1 | up-regulates | NFATC4 | activates | R-2712 | 10 | 8 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-19568 | NF1 | up-regulates | NFATC4 | activates | R-2705 | 10 | 8 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)L19IL2, AS-1409, ALEPLASININ, L19TNFA, L19SIP 131I, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN |
CMF-19569 | NF1 | up-regulates | NFATC4 | activates | R-2710 | 10 | 8 | Drugs (1) |
CMF-19570 | NF1 | up-regulates | NFATC4 | activates | R-2707 | 10 | 8 | Drugs (4) |
CMF-20281 | ENAM | down-regulates | NFATC4 | activates | R-2705 | 10 | 2 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)L19IL2, AS-1409, ALEPLASININ, L19TNFA, L19SIP 131I, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN |
CMF-20282 | ENAM | down-regulates | NFATC4 | activates | R-2707 | 10 | 2 | Drugs (4) |
CMF-22180 | PDGFRA | down-regulates | NFATC4 | activates | R-2712 | 10 | 4 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-22182 | PDGFRA | down-regulates | NFATC4 | activates | R-2705 | 10 | 4 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)L19IL2, AS-1409, ALEPLASININ, L19TNFA, L19SIP 131I, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN |
CMF-22183 | PDGFRA | down-regulates | NFATC4 | activates | R-2707 | 10 | 4 | Drugs (4) |
CMF-22937 | IDH1 | down-regulates | NFATC4 | activates | R-2712 | 10 | 7 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-22940 | IDH1 | down-regulates | NFATC4 | activates | R-2705 | 10 | 7 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)L19IL2, AS-1409, ALEPLASININ, L19TNFA, L19SIP 131I, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN |
CMF-22941 | IDH1 | down-regulates | NFATC4 | activates | R-2710 | 10 | 7 | Drugs (1) |
CMF-22942 | IDH1 | down-regulates | NFATC4 | activates | R-2707 | 10 | 7 | Drugs (4) |
CMF-26408 | MAGEB1 | down-regulates | NFATC4 | activates | R-2705 | 10 | 3 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)L19IL2, AS-1409, ALEPLASININ, L19TNFA, L19SIP 131I, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN |
CMF-26409 | MAGEB1 | down-regulates | NFATC4 | activates | R-2707 | 10 | 3 | Drugs (4) |
CMF-30550 | JHDM1D | down-regulates | NFATC4 | activates | R-2712 | 10 | 4 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-30552 | JHDM1D | down-regulates | NFATC4 | activates | R-2705 | 10 | 4 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)L19IL2, AS-1409, ALEPLASININ, L19TNFA, L19SIP 131I, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN |
CMF-30553 | JHDM1D | down-regulates | NFATC4 | activates | R-2710 | 10 | 4 | Drugs (1) |
CMF-30905 | NPY5R | down-regulates | NFATC4 | activates | R-2705 | 10 | 2 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)L19IL2, AS-1409, ALEPLASININ, L19TNFA, L19SIP 131I, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN |
CMF-30906 | NPY5R | down-regulates | NFATC4 | activates | R-2710 | 10 | 2 | Drugs (1) |